Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Company Profile Travere Therapeutics Inc TVTX

Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States. The company’s products include FILSPARI (sparsentan), a once-daily, oral medication designed to target two critical pathways in the disease progression of IgA Nephropathy (endothelin 1 and angiotensin-II); and Thiola... see more

Showcase News Releases

Showcase news

Mink Ventures Corp.
Mink Ventures Engages Independent Trading Group as Market Maker
Nine Mile Metals Ltd.
Canadian Investment Regulatory Organization Trade Resumption - NINE
Nine Mile Metals Ltd.
Nine Mile Metals Announces Certified Assays from DDH-WD-25-01 of 3.83% CuEq Over 22.65 Meters (39.52 g/t Ag, 0.96 g/t Au, 0.99% Cu, 2.25% Pb, 1.61% Zn) and 4.33% CuEq Over 17.65 Meters (42.5 g/t Ag, 1.01 g/t Au, 1.2% Cu, 2.62% Pb, 2.05% Zn) Including 1.21 g/t Au and 50.33 g/t Ag Over 13.00 Meters

More Showcase News Releases »